[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 181,490,688
  • Shares Outstanding, K 539,685
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 10,568 M
  • EBITDA $ 16,935 M
  • 60-Month Beta 0.44
  • Price/Sales 4.84
  • Price/Cash Flow 9.75
  • Price/Book 19.35

Options Overview Details

View History
  • Implied Volatility 25.72% (+1.09%)
  • Historical Volatility 24.40%
  • IV Percentile 36%
  • IV Rank 29.78%
  • IV High 39.99% on 05/28/25
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 2) 7.40 (2.20%)
  • Put/Call Vol Ratio 0.38
  • Today's Volume 6,405
  • Volume Avg (30-Day) 6,962
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 109,149
  • Open Int (30-Day) 100,386
  • Expected Range 329.36 to 344.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 36 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.64
  • Number of Estimates 12
  • High Estimate $6.23
  • Low Estimate $5.30
  • Prior Year $6.02
  • Growth Rate Est. (year over year) -6.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
320.52 +4.99%
on 05/05/26
356.90 -5.72%
on 04/20/26
-13.32 (-3.81%)
since 04/13/26
3-Month
320.52 +4.99%
on 05/05/26
391.29 -14.00%
on 03/02/26
-32.69 (-8.85%)
since 02/13/26
52-Week
261.43 +28.72%
on 05/14/25
391.29 -14.00%
on 03/02/26
+66.05 (+24.42%)
since 05/13/25

Most Recent Stories

More News
FDA Commissioner Marty Makary Resigns Amid Leadership Turmoil and Biotech Industry Backlash

US Food and Drug Administration Commissioner Marty Makary is resigning after 13 months in the role, according to President Donald Trump, marking another leadership shakeup across federal health agencies....

KO : 80.39 (+0.45%)
MRNA : 50.44 (-5.31%)
AMGN : 336.90 (+0.18%)
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , May 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m. PT on Wednesday, May 13, 2026. Peter...

AMGN : 336.90 (+0.18%)
5 Must-Read Analyst Questions From Amgen’s Q1 Earnings Call

5 Must-Read Analyst Questions From Amgen’s Q1 Earnings Call

AMGN : 336.90 (+0.18%)
2 Healthcare Stocks on Our Watchlist and 1 That Underwhelm

2 Healthcare Stocks on Our Watchlist and 1 That Underwhelm

TMO : 447.36 (-2.60%)
CAH : 185.95 (+1.86%)
AMGN : 336.90 (+0.18%)
Amgen Expands Puerto Rico Biologics Facility With Additional $300M Investment Amid Tariff Pressure

Amgen ($AMGN) is investing an additional $300 million to expand its biologics manufacturing facility in Puerto Rico, bringing its recent commitments to the site to nearly $1 billion as drugmakers increase...

NVS : 149.73 (+1.06%)
AMGN : 336.90 (+0.18%)
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology

AMGN : 336.90 (+0.18%)
2 Nasdaq 100 Stocks with Competitive Advantages and 1 We Question

2 Nasdaq 100 Stocks with Competitive Advantages and 1 We Question

WDAY : 117.04 (-1.33%)
AMGN : 336.90 (+0.18%)
MRVL : 177.74 (+8.05%)
S&P 500 and Nasdaq 100 Post Record Highs on Solid Earnings

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.29%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.94%. June E-mini...

MSTR : 178.73 (-3.09%)
ALK : 38.49 (-0.62%)
AAPL : 299.41 (+1.56%)
INTU : 374.88 (-3.32%)
SNDK : 1,454.67 (+0.18%)
DDOG : 204.21 (+2.14%)
GLXY : 31.01 (-1.18%)
VEEV : 156.19 (-2.03%)
$IUXX : 29,405.94 (+1.17%)
AMGN : 336.90 (+0.18%)
COIN : 203.36 (-2.06%)
CLX : 92.31 (+3.59%)
Stocks Climb on Strong Earnings and Crude Oil Weakness

The S&P 500 Index ($SPX ) (SPY ) today is up +0.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. June E-mini S&P futures (ESM26...

MSTR : 178.73 (-3.09%)
AAPL : 299.41 (+1.56%)
INTU : 374.88 (-3.32%)
ADI : 433.26 (+3.24%)
DDOG : 204.21 (+2.14%)
GLXY : 31.01 (-1.18%)
VEEV : 156.19 (-2.03%)
$IUXX : 29,405.94 (+1.17%)
AMGN : 336.90 (+0.18%)
COIN : 203.36 (-2.06%)
CLX : 92.31 (+3.59%)
ZNM26 : 110-020 (+0.03%)
Stocks Supported by Apple’s Earnings and Weaker Crude Prices

The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.79%. June E-mini S&P futures (ESM26...

AAPL : 299.41 (+1.56%)
INTU : 374.88 (-3.32%)
ADI : 433.26 (+3.24%)
DDOG : 204.21 (+2.14%)
VEEV : 156.19 (-2.03%)
TXN : 307.38 (+4.14%)
$IUXX : 29,405.94 (+1.17%)
AMGN : 336.90 (+0.18%)
CLX : 92.31 (+3.59%)
ZNM26 : 110-020 (+0.03%)
ESM26 : 7,479.25 (+0.71%)
QCOM : 213.93 (+1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 348.61
2nd Resistance Point 343.55
1st Resistance Point 339.92
Last Price 336.90
1st Support Level 331.23
2nd Support Level 326.17
3rd Support Level 322.54

See More

52-Week High 391.29
Fibonacci 61.8% 341.68
Last Price 336.90
Fibonacci 50% 326.36
Fibonacci 38.2% 311.04
52-Week Low 261.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.